Histiocytic disorders

Hematology Journal

Volumn 4, Issue 3, 2003, Pages 171-179

  Aricò, Maurizio ^a   Clementi, Rita ^b   Caselli, Désirée ^a   Danesino, Cesare ^b,c  

^a Ospedale dei Bambini G Di Cristina   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Hemophagocytosis; Histiocytosis; Langerhans; Natural killer; Perforin

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; STEROID; THYMOCYTE ANTIBODY; VINBLASTINE;

BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HISTIOCYTOSIS; HISTIOCYTOSIS X; HUMAN; IMMUNOTHERAPY; LINKAGE ANALYSIS; PATHOPHYSIOLOGY; RETICULOSIS; REVIEW;

DIAGNOSIS, DIFFERENTIAL; HISTIOCYTOSIS; HISTIOCYTOSIS, LANGERHANS-CELL; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS;

EID: 0038729652     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200253     Document Type: Review

References (74)

1. Arceci RJ, Longley BJ, Emanuel PD. Atypical cellular disorders. Hematology (Am Soc Hematol Educ Program) 2002; 297-314.
2. Favara BE, Feller AC, Pauli M, Jaffe ES, Weiss LM, Aricò M, Bucsky P, Egeler RM, Elinder G, Gadner H, Gresik M, Henter JI, Imashuku S, Janka-Schaub G, Jaffe R, Ladisch S, Nezelof C, Pritchard J. for the WHO Committee on Histiocytic/Reticulum cell proliferations and the Reclassification Working Group of the Histiocyte Society. Contemporary classification of histiocytic disorders. Med Pediatr Oncol 1997; 29: 157-166.
3. Kaatsch P, Maaf HG, Michaelis J (eds). Jahresbericht 1993 des Deutschen Kinderkrebregisters, Vol 6. IMSD Johannes Gutenberg, Universität Institut für Medizinshe Statistik und Dokumentation: Mainz, 1994, pp 14-15.
4. Schmitz L, Favara BE. Nosology and pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998; 12: 221-246.
5. Broadbent V, Gadner H, Komp DM, Ladisch S. Histiocytosis syndromes in children: II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Clinical Writing Group of the Histiocyte Society. Med Pediatr Oncol 1989; 17: 492-495.
6. Lampert F. Langerhans cell histiocytosis. Historical perspectives. Hematol Oncol Clin North Am 1998; 12: 213-219.
7. Nezelof C, Basset F, Rousseau MF: Histiocytosis X: histogenetic arguments for a Langerhans cell origin. Biomedicine 1973; 18: 365-372.
8. Aricò M, Egeler M. Clinical aspects of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998; 12: 247-258.
9. Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg PJ. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer 1999; 85: 2278-2290.
10. Kilpatrick SE, Wenger DE, Gilchrist GS, Shives TC, Wollan PC, Unni KK. Langerhans' cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer 1995; 76: 2471-2484.
11. The French Langerhans' Cell Histiocytosis Study Group: A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child 1996; 75: 17-24.
12. Willis B, Ablin A, Weinberg V, Zoger S, Wara WM, Matthay KK. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco. J Clin Oncol 1996; 14: 2073-2082.
13. Meyer JS, De Camargo B. The role of radiology in the diagnosis and follow-up of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998; 12: 307-326.
14. Munn S, Chu AC. Langerhans cell histiocytosis of the skin. Hematol Oncol Clin North Am 1998; 12: 269-286.
15. Hashimoto K, Bale GF, Hawkins HK, Langston C, Pritzker MS. Congenital self-healing reticulohistiocytosis (Hashimoto-Pritzker type). Int J Dermatol 1986; 25: 516-523.
16. Melendez HV, Dhawan A, Mieli-Vergani G, Rela M, Heaton ND, Pritchard J et al. Liver transplantation for Langerhans' cell histiocytosis - a case report and literature review. Transplantation 1996; 62: 1167-1171.
17. Gadner H, Grois N, Aricò M, Broadbent V, Ceci A, Jakobson A et al. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 2001; 138: 728-734.
18. Braier J, Chantada G, Rosso D, Bernaldez P, Amaral D, Latella A et al. Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution. Pediatr Hematol Oncol 1999; 16: 377-385.
19. Vassallo R, Ryu JH, Schroeder DR, Decker PA, Limper AH. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med 2002; 346: 484-490.
20. McClain KL, Gonzalez JM, Jonkers R, De Juli E, Egeler M. Need for a cooperative study: pulmonary Langerhans cell histiocytosis and its management in adults. Med Pediatr Oncol 2002; 39: 35-39.
21. Aricò M, Nichols KE, Danesino C. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med 2000; 343: 1654.
22. Loire R, Brune J. Severe late stage lesions of pulmonary histiocytosis X. Report of 3 transplantations. Rev Mal Respir 1993; 10: 223-228.
23. Geissmann F, Thomas C, Emile JF, Micheau M, Canioni D, Cerf-Bensussan N et al. Digestive tract involvement in Langerhans cell histiocytosis. The French Langerhans Cell Histiocytosis Study Group. J Pediatr 1996; 129: 836-845.
24. Nanduri VR, Kelly K, Malone M, Milla P, Pritchard J. Colon involvement in Langerhans' cell histiocytosis. J Pediatr Gastroenterol Nutr 1999; 29: 462-466.
25. Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S et al. Central diabetes insipidus in children and young adults. N Engl J Med 2000; 343: 998-1007.
26. Maghnie M, Aricò M, Villa A, Genovese E, Beluffi G, Severi F. MR of the hypothalamic-pituitary axis in Langerhans cell histiocytosis. Am J Neuroradiol 1992; 13: 1365-1371.
27. Maghnie M, Villa A, Aricò M, Larizza D, Pezzotta S, Beluffi G et al. Correlation between magnetic resonance imaging of posterior pituitary and neurohypophyseal function in children with diabetes insipidus. J Clin Endocrinol Metab 1992; 74: 795-800.
28. Maghnie M, Genovese E, Bernasconi S, Binda S, Aricò M. Persistent high MR signal of the posterior pituitary gland in central diabetes insipidus. Am J Neuroradiol 1997; 18: 1749-1752.
29. Kaltsas GA, Powles TB, Evanson J, Plowman PN, Drinkwater JE, Jenkins PJ et al. Hypothalamo-pituitary abnormalities in adult patients with Langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab 2000; 85: 1370-1376.
30. Rosenzweig KE, Arceci RJ, Tarbell NJ. Diabetes insipidus secondary to Langerhans' cell histiocytosis: is radiation therapy indicated? Med Pediatr Oncol 1997; 29: 36-40.
31. Maghnie M, Bossi G, Klersy C, Cosi G, Genovese E, Aricò M. Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood Langerhans cell histiocytosis. J Clin Endocrinol Metab 1998; 83: 3089-3094.
32. Nanduri VR, Bareille P, Pritchard J, Stanhope R. Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis. Clin Endocrinol 2000; 53: 509-515.
33. Grois NG, Favara BE, Mostbeck GH, Prayer D. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998; 12: 287-305.
34. Axiotis CA, Merino MJ, Duray PH. Langerhans cell histiocytosis of the female genital tract. Cancer 1991; 67: 1650-1660.
35. Roesler J, Kofink B, Wendisch J, Heyden S, Paul D, Friedrich W et al. Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp Hematol 1999; 27: 1368-1374.
36. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol 1990; 7: 19-73.
37. Titgemeyer C, Grois N, Minkov M, Flucher-Wolfram B, Gatterer-Menz I, Gadner H. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study. Med Pediatr Oncol 2001; 37: 108-114.
38. Hoeger PH, Nanduri VR, Harper JI, Atherton DA, Pritchard J. Long term follow up of topical mustine treatment for cutaneous langerhans cell histiocytosis. Arch Dis Child 2000; 82: 483-487.
39. Minkov M, Grois N, Heitger A, Potschger U, Westermeier T, Gadner H. DAL-HX Study Group. Response to initial treatment of multisystern Langerhans cell histiocytosis: an important prognostic indicator. Med Pediatr Oncol 2002; 39: 581-585.
40. Conter V, Reciputo A, Arrigo C, Bozzato N, Sala A, Aricò M. Bone marrow transplantation for refractory Langerhans' cell histiocytosis. Haematologica 1996; 81: 468-471.
41. Aricò M, Girschikofsky M, Généreau T, Klersy C, McClain K, Grois N et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Submitted.
42. Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, Gilliland DG. Langerhans'-cell histiocytosis (histiocytosis X) - a clonal proliferative disease. N Engl J Med 1994; 331:154-160.
43. Yousem SA, Colby TV, Chen YY, Chen WG, Weiss LM. Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 2001; 25: 630-636.
44. Holter W, Ressmann G, Grois N, Lehner M, Parolini O, Gadner H. Normal monocyte-derived dendritic cell function in patients with Langerhans-cell-histiocytosis. Med Pediatr Oncol 2002; 39: 181-186.
45. Aricò M, Nichols K, Whitlock JA, Arceci R, Haupt R, Mittler U, Kuhne T, Lombardi A, Ishii E, Egeler RM, Danesino C. Familial clustering of Langerhans cell histiocytosis. Br J Haematol 1999; 107: 883-888.
46. Scappaticci S, Danesino C, Rossi E, Klersy C, Fiori GM, Clementi R, Spica Russotto V, Bossi G, Aricò M for the AIEOP-Istiocitosi Group. Cytogenetic abnormalities in PHA-stimulated lymphocytes from patients with Langerhans cell histiocytosis. Br J Haematol 2000; 111: 258-262.
47. LCH Cancer, Egeler RM, Neglia JP, Aricò M, Favara BE, Heitger A, Nesbit ME et al. The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society. Hematol Oncol Clin North Am 1998; 12: 369-378.
48. Aricò M, Danesino C. Langerhans' cell histiocytosis: is there a role for genetics? Haematologica 2001; 86: 1009-1014.
49. Farquhar J, Claireaux A. Familial haemophagocytic reticulosis. Arch Dis Child 1952; 27: 519-525.
50. Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983; 140: 221-227.
51. Aricò M, Janka G, Fischer A, Henter JI, Blanche S, Elinder G, Martinetti M, Rusca MP. Hemophagocytic lymphohistiocytosis: diagnosis, treatment and prognostic factors. Report of 122 Children from the International Registry. Leukemia 1996; 10: 197-202.
52. Clementi R, Emmi L, Maccario R, Liotta F, Moretta L, Danesino C et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood 2002; 100: 2266-2267.
53. Perez N, Virelizier JL, Arenzana-Seisdedos F, Fischer A, Griscelli C. Impaired natural killer activity in lymphohistiocytosis syndrome. J Pediatr 1984; 104: 569-573.
54. Aricò M, Nespoli L, Maccario R, Montagna D, Bonetti F, Caselli D et al. Natural cytotoxicity impairment in familial hemophagocytic lymphohistiocytosis. Arch Dis Child 1988; 63: 292-296.
55. Schneider EM, Lorenz I, Muller-Rosemberg M, Stembahc G, Kron M, Janka-Schaub G. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-induced apoptosis. Blood 2002; 100: 2891-2898.
56. Henter J-I, Elinder st G. and the FHL Study Group of the Histiocyte Society. Diagnostic Guidelines for Hemophagocytic Lymphohistiocytosis. Semin Oncol 1991; 18: 29-33.
57. Ohadi M, Lalloz MR, Sham P, Zhao J, Dearlove AM, Shiach C et al. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet 1999; 64: 165-171.
58. Dufourcq-Lagelouse R, Jabado N, Le Deist F, Stephan JL, Souillet G, Bruin M et al. Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity. Am J Hum Genet 1999; 64: 172-179.
59. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA et al. Perform gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999; 286: 1957-1959.
60. Ericson KG, Fadeel B, Nilsson-Ardnor S, Sderhll C, Samuelsson AC, Janka G et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet 2001; 68, 590-597.
61. Clementi R, zur Stadt U, Savoldi G, Varotto S, Conter V, De Fusco C et al. Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis. J Med Genet 2001; 38: 643-646.
62. Suga N, Takada H, Nomura A, Ohga S, Ishii E, Ihara K et al. Perforin defects of primary haemophagocytic lymphohistiocytosis in Japan. Br J Haematol 2002; 116: 346-349.
63. Egeler RM, Favara BE, van Meurs M, Laman JD, Claassen E. Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood. 1999, 94: 4195-4201.
64. Aricò M, Danesino C, Pende D, Moretta L. Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol 2001; 114: 761-769.
65. Fadeel B, Orrenius S, Henter JI. Induction of apoptosis and caspase activation in cells obtained from familial haemophagocytic lymphohistiocytosis patients. Br J Haematol 1999; 106: 406-415.
66. Henter J-I, Samuelsson-Horne AC, Aricò M, Egeler RM, Elinder G, Filipovich AH et al. for the Histiocyte Society. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100: 2367-2373.
67. Jabado N, de Graeff-Meeder ER, Cavazzana-Calvo M, Haddad E, Le Deist F, Benkerrou M et al. Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors. Blood 1997; 90: 4743-4748.
68. Durken M, Finckenstein FG, Janka GE. Bone marrow transplantation in hemophagocytic lymphohistiocytosis. Leukemia Lymphoma 2001; 41: 89-95.
69. Stary J, Sedlacek P, Vodvarkova S, Polouckova A, Formankova R, Gasova Z et al. Transplantation of highly purified CD34+ hematologic peripheral stem cells from haploidentical related donors in the treatment of children with non-malignant diseases. Cas Lek Cesk 2002; 141: 176-181.
70. Ardeshna KM, Hollifield J, Chessells JM, Veys P, Webb DK. Outcome for children after failed transplant for primary haemophagocytic lymphohistiocytosis. Br J Haematol 2001; 115: 949-952.
71. Stephan JL, Donadieu J, Ledeist F, Blanche S, Griscelli C, Fischer A. Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A. Blood 1993; 82: 2319-2323.
72. Aricò M, Imashuku S, Clementi R, Hibi S, Teramura T, Danesino C et al. Hemophagocytic lymphohistiocytosis due to germline mutations in DSHP, the X-linked lymphoproliferative disease gene. Blood 2001; 97: 1131-1133.
73. Aricò M, Zecca M, Santoro N, Caselli D, Maccario R, Danesino C et al. Successful treatment of Griscelli syndrome with unrelated donor allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 995-998.
74. Aricò M, Allen M, Brusa S, Clementi, Pende D, Maccario R et al. Hemophagocytic lymphohistiocytosis: proposal of a diagnostic algorithm based on perforin expression. Br J Haematol 2002; 119: 180-188.